Literature DB >> 24070156

Review of organic causes of fecal incontinence in children: evaluation and treatment.

Lusine Ambartsumyan1, Samuel Nurko.   

Abstract

Even though fecal incontinence (FI) in children is most commonly the result of functional constipation, there are organic conditions that can be associated with incontinence. FI has a major impact on the quality of life of those children who experience it. The general objectives of any bowel program are to achieve predictability and independence. This is achieved by manipulating colonic transit and stool consistency and by producing more controlled evacuations, usually with the use of rectal interventions. Dietary interventions and medications can be used to change stool consistency or to manipulate transit by accelerating or slowing it down. Biofeedback or other interventions that increase sphincter pressure can also be used to improve anorectal function. Enemas or suppositories can be used to empty the sigmoid colon in a more controlled manner. With the recent advent of the antegrade colonic enemas, the patient can have predictable bowel movements and become independent.

Entities:  

Mesh:

Year:  2013        PMID: 24070156     DOI: 10.1586/17474124.2013.832500

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  2 in total

1.  Are all patients with short segment Hirschsprung's disease equal? A retrospective multicenter study.

Authors:  Patrick Ho Yu Chung; Kenneth Kak Yuen Wong; Paul Kwong Hang Tam; Michael Wai Yip Leung; Nicholas Sih Yin Chao; Kelvin Kam Wing Liu; Edwin Kin Wai Chan; Yuk Him Tam; Kim Hung Lee
Journal:  Pediatr Surg Int       Date:  2017-10-26       Impact factor: 1.827

2.  Three-dimensional High-resolution Anorectal Manometry in Children With Non-retentive Fecal Incontinence.

Authors:  Marcin Banasiuk; Marcin Dziekiewicz; Magdalena Dobrowolska; Barbara Skowrońska; Łukasz Dembiński; Aleksandra Banaszkiewicz
Journal:  J Neurogastroenterol Motil       Date:  2022-04-30       Impact factor: 4.924

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.